| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.49▲ | 2.45▲ | 2.45▲ | 2.41▲ | 2.41▲ |
| MA10 | 2.46▲ | 2.44▲ | 2.42▲ | 2.40▲ | 3.14▼ |
| MA20 | 2.43▲ | 2.41▲ | 2.37▲ | 2.39▲ | 5.14▼ |
| MA50 | 2.41▲ | 2.39▲ | 2.38▲ | 3.39▼ | 6.98▼ |
| MA100 | 2.37▲ | 2.39▲ | 2.35▲ | 5.23▼ | 7.14▼ |
| MA200 | 2.38▲ | 2.36▲ | 2.51▲ | 6.83▼ | 5.92▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | 0.008▲ | 0.015▲ | 0.107▲ | -0.266▼ |
| RSI | 67.312▲ | 66.239▲ | 64.803▲ | 45.308▼ | 24.941▼ |
| STOCH | 95.921▲ | 49.425 | 64.157 | 61.487 | 24.993 |
| WILL %R | -6.667▲ | -4.762▲ | -4.762▲ | -2.439▲ | -76.098▼ |
| CCI | 156.012▲ | 198.954▲ | 184.739▲ | 127.476▲ | -73.515 |
|
Wednesday, June 29, 2022 02:37 PM
Avadel Pharmaceuticals (AVDL) is trading 18% higher after the company said it expects to receive tentative approval from the U.S ...
|
|
Wednesday, June 29, 2022 01:07 PM
Pursuing strategies to accelerate final approval of FT218 NDA Optimizing cost structure to fund strategic priorities and extend cash runway Continuing key activities to accelerate launch timing of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/07/22 | 2.41 | 2.53 | 2.38 | 2.52 | 384,192 |
| 30/06/22 | 2.50 | 2.50 | 2.32 | 2.44 | 313,500 |
| 29/06/22 | 2.31 | 2.361 | 2.26 | 2.34 | 271,243 |
| 28/06/22 | 2.40 | 2.49 | 2.32 | 2.34 | 410,812 |
| 27/06/22 | 2.30 | 2.48 | 2.27 | 2.43 | 325,800 |
| 24/06/22 | 2.47 | 2.4801 | 2.31 | 2.31 | 537,989 |
| 23/06/22 | 2.39 | 2.44 | 2.2801 | 2.43 | 544,463 |
| 22/06/22 | 2.41 | 2.48 | 2.335 | 2.35 | 398,120 |
| 21/06/22 | 2.38 | 2.53 | 2.36 | 2.46 | 606,706 |
| 17/06/22 | 2.35 | 2.49 | 2.315 | 2.34 | 1,039,925 |
|
|
||||
|
|
||||
|
|